1. Johnson NR, Gannon OM, Savage NW, Batstone MD. Frequency of odontogenic cysts and tumors: a systematic review. J Investig Clin Dent. 2014;5:9-14.

https://doi.org/10.1111/jicd.12044

PMid:23766099 

2. Gaitán-Cepeda LA, Quezada-Rivera D, Tenorio-Rocha F, Leyva-Huerta ER. Reclassification of odontogenic keratocyst as tumour. Impact on the odontogenic tumours prevalence. Oral Dis. 2010;16:185-7.

https://doi.org/10.1111/j.1601-0825.2009.01625.x

PMid:19747351 

3. Soluk-Tekkeşin M, Wright JM. The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2017 (4th) Edition. Turk Patoloji Derg. 2018;34:1-18.

PMid:28984343

4. Gomes CC, Guimarães LM, Diniz MG, Gomez RS. Molecular alterations in odontogenic keratocysts as potential therapeutic targets. J Oral Pathol Med. 2017;46:877-82.

https://doi.org/10.1111/jop.12591

PMid:28489259 

5. Levanat S, Pavelić B, Crnić I, Oresković S, Manojlović S. Involvement of PTCH gene in various noninflammatory cysts. J Mol Med (Berl). 2000;78:140-6.

https://doi.org/10.1007/s001090000090

PMid:10868476 

6. Speight PM, Takata T. New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours. Virchows Arch. 2018;472:331-39.

https://doi.org/10.1007/s00428-017-2182-3

PMid:28674741 PMCid:PMC5886999

7. Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO. Ameloblastoma: current etiopathological concepts and management. Oral Dis. 2018;24:307-16.

https://doi.org/10.1111/odi.12646

PMid:28142213 

8. Heikinheimo K, Jee KJ, Niini T, Aalto Y, Happonen RP, Leivo I, et al. Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res. 2002;81:525-30.

https://doi.org/10.1177/154405910208100805

PMid:12147741 

9. Heikinheimo K, Kurppa KJ, Laiho A, Peltonen S, Berdal A, Bouattour A, et al. Early dental epithelial transcription factors distinguish ameloblastoma from keratocystic odontogenic tumor. J Dent Res. 2015;94:101-11.

https://doi.org/10.1177/0022034514556815

PMid:25398365 

10. Sukarawan W, Simmons D, Suggs C, Long K, Wright JT. WNT5A expression in ameloblastoma and its roles in regulating enamel epithelium tumorigenic behaviors. Am J Pathol. 2010;176:461-71.

https://doi.org/10.2353/ajpath.2010.090478

PMid:20008136 PMCid:PMC2797904

11. Siar CH, Nagatsuka H, Han PP, Buery RR, Tsujigiwa H, Nakano K, et al. Differential expression of canonical and non-canonical Wnt ligands in ameloblastoma. J Oral Pathol Med. 2012;41:332-9.

https://doi.org/10.1111/j.1600-0714.2011.01104.x

PMid:22077561 

12. Gurgel CA, Buim ME, Carvalho KC, Sales CB, Reis MG, de Souza RO, et al. Transcriptional profiles of SHH pathway genes in keratocystic odontogenic tumor and ameloblastoma. J Oral Pathol Med. 2014;43:619-26.

https://doi.org/10.1111/jop.12180

PMid:24930892 

13. Shimada Y, Katsube K, Kabasawa Y, Morita K, Omura K, Yamaguchi A, et al. Integrated genotypic analysis of hedgehog-related genes identifies subgroups of keratocystic odontogenic tumor with distinct clinicopathological features. PLoS One. 2013;8:e70995.

https://doi.org/10.1371/journal.pone.0070995

PMid:23951062 PMCid:PMC3737235

14. Brown NA, Betz BL. Ameloblastoma: A Review of Recent Molecular Pathogenetic Discoveries. Biomark Cancer. 2015;7:19-24.

https://doi.org/10.4137/BIC.S29329

PMid:26483612 PMCid:PMC4597444

15. Guimarães DM, Antunes DM, Saturno JL, Massuda F, Paiva KB, Nunes FD. Immunohistochemical expression of WNT5A and MMPs in odontogenic epithelial tumors and cysts. Acta Histochem. 2015;117:667-74.

https://doi.org/10.1016/j.acthis.2015.10.006

PMid:26558991 

16. Juuri E, Isaksson S, Jussila M, Heikinheimo K, Thesleff I. Expression of the stem cell marker, SOX2, in ameloblastoma and dental epithelium. Eur J Oral Sci. 2013;121:509-16.

https://doi.org/10.1111/eos.12095

PMid:24148099 

17. Weina K, Utikal J. SOX2 and cancer: current research and its implications in the clinic. Clin Transl Med. 2014;3:19.

https://doi.org/10.1186/2001-1326-3-19

PMid:25114775 PMCid:PMC4126816

18. Lo Muzio L, Staibano S, Pannone G, Bucci P, Nocini PF, Bucci E, et al. Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res. 1999;78:1345-53.

https://doi.org/10.1177/00220345990780070901

PMid:10403462 

19. Luke JJ, Van De Wetering CI, Knudson CM. Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability. Cell Death Differ. 2003;10:740-8.

https://doi.org/10.1038/sj.cdd.4401233

PMid:12761582 

20. Wang Y, Sun HJ, Li RG, Wang XM, Cheng ZQ, Lou N. Reprogramming factors induce proliferation and inhibit apoptosis of melanoma cells by changing the expression of particular genes. Mol Med Rep. 2019;19:967-73.

https://doi.org/10.3892/mmr.2018.9753

PMid:30569122

21. Justilien V, Walsh MP, Ali SA, Thompson EA, Murray NR, Fields AP. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma. Cancer Cell. 2014;25:139-51.

https://doi.org/10.1016/j.ccr.2014.01.008

PMid:24525231 PMCid:PMC3949484

22. Haston S, Pozzi S, Carreno G, Manshaei S, Panousopoulos L, Gonzalez-Meljem JM, et al. MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma. Development. 2017;144:2141-52.

https://doi.org/10.1242/dev.150490

PMid:28506993 PMCid:PMC5482995

23. Wright JM, Vered M. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors. Head Neck Pathol. 2017;11:68-77.

https://doi.org/10.1007/s12105-017-0794-1

PMid:28247226 PMCid:PMC5340735

24. Gopalan V, Ebrahimi F, Islam F, Vider J, Qallandar OB, Pillai S, et al. Tumour suppressor properties of miR-15a and its regulatory effects on BCL2 and SOX2 proteins in colorectal carcinomas. Exp Cell Res. 2018;370:245-53.

https://doi.org/10.1016/j.yexcr.2018.06.025

PMid:29958837 

25. Juuri E, Saito K, Ahtiainen L, Seidel K, Tummers M, Hochedlinger K, et al. Sox2+ stem cells contribute to all epithelial lineages of the tooth via Sfrp5+ progenitors. Dev Cell. 2012;23:317-28.

https://doi.org/10.1016/j.devcel.2012.05.012

PMid:22819339 PMCid:PMC3690347

26. Patra SK, Deb M, Patra A. Molecular marks for epigenetic identification of developmental and cancer stem cells. Clin Epigenetics. 2011;2:27-53.

https://doi.org/10.1007/s13148-010-0016-0

PMid:22704268 PMCid:PMC3365374

27. Liu K, Lin B, Zhao M, Yang X, Chen M, Gao A, Liu F, Que J, et al. The multiple roles for Sox2 in stem cell maintenance and tumorigenesis. Cell Signal. 2013;25:1264-71.

https://doi.org/10.1016/j.cellsig.2013.02.013

PMid:23416461 PMCid:PMC3871517

28. Wuebben EL, Rizzino A. The dark side of SOX2: cancer - a comprehensive overview. Oncotarget. 2017;8:44917-43.

https://doi.org/10.18632/oncotarget.16570

PMid:28388544 PMCid:PMC5546531

29. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet. 2009;41:1238-42.

https://doi.org/10.1038/ng.465

PMid:19801978 PMCid:PMC2783775

30. Freier K, Knoepfle K, Flechtenmacher C, Pungs S, Devens F, Toedt G, et al. Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma. Genes Chromosomes Cancer. 2010;49:9-16.

https://doi.org/10.1002/gcc.20714

PMid:19787784 

31. Lei Y, Jaradat JM, Owosho A, Adebiyi KE, Lybrand KS, Neville BW, et al. Evaluation of SOX2 as a potential marker for ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:608-16.e1.

https://doi.org/10.1016/j.oooo.2014.01.017

PMid:24603057 

32. Juuri E, Jussila M, Seidel K, Holmes S, Wu P, Richman J, et al. Sox2 marks epithelial competence to generate teeth in mammals and reptiles. Development. 2013;140:1424-32.

https://doi.org/10.1242/dev.089599

PMid:23462476 PMCid:PMC3596986

33. Kichi E, Enokiya Y, Muramatsu T, Hashimoto S, Inoue T, Abiko Y, et al. Cell proliferation, apoptosis and apoptosis-related factors in odontogenic keratocysts and in dentigerous cysts. J Oral Pathol Med. 2005;34:280-6.

https://doi.org/10.1111/j.1600-0714.2005.00314.x

PMid:15817071 

34. Hoyos Cadavid AM, Kaminagakura E, Rodrigues MFSD, Pinto CAL, Teshima THN, Alves FA. Immunohistochemical evaluation of Sonic Hedgehog signaling pathway proteins (Shh, Ptch1, Ptch2, Smo, Gli1, Gli2, and Gli3) in sporadic and syndromic odontogenic keratocysts. Clin Oral Investig. 2019;23:153-59.

https://doi.org/10.1007/s00784-018-2421-2

PMid:29564556 

35. Chari NS, McDonnell TJ. The sonic hedgehog signaling network in development and neoplasia. Adv Anat Pathol. 2007;14:344-52.

https://doi.org/10.1097/PAP.0b013e3180ca8a1d

PMid:17717435 

36. Merchant AA, Matsui W. Targeting Hedgehog--a cancer stem cell pathway. Clin Cancer Res. 2010;16:3130-40.

https://doi.org/10.1158/1078-0432.CCR-09-2846

PMid:20530699 PMCid:PMC2888641

37. Bigelow RL, Chari NS, Unden AB, Spurgers KB, Lee S, Roop DR, et al. Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1. J Biol Chem. 2004;279:1197-205.

https://doi.org/10.1074/jbc.M310589200

PMid:14555646 

38. Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348:334-6.

https://doi.org/10.1038/348334a0

PMid:2250705 

39. Huang C, Lu H, Li J, Xie X, Fan L, Wang D, et al. SOX2 regulates radioresistance in cervical cancer via the hedgehog signaling pathway. Gynecol Oncol. 2018;151:533-41.

https://doi.org/10.1016/j.ygyno.2018.10.005

PMid:30336948 

40. Kar S, Sengupta D, Deb M, Pradhan N, Patra SK. SOX2 function and Hedgehog signaling pathway are co-conspirators in promoting androgen independent prostate cancer. Biochim Biophys Acta Mol Basis Dis. 2017;1863:253-65.

https://doi.org/10.1016/j.bbadis.2016.11.001

PMid:27816521 

41. Diniz MG, Gomes CC, de Castro WH, Guimarães AL, De Paula AM, Amm H, et al. miR-15a/16-1 influences BCL2 expression in keratocystic odontogenic tumors. Cell Oncol (Dordr). 2012;35:285-91.

https://doi.org/10.1007/s13402-012-0087-3

PMid:22684875